Aurobindo Pharma to acquire entire stake in MViyeS

19 Oct 2020 Evaluate

Aurobindo Pharma has entered into a share purchase agreement to acquire 100% equity share capital of MViyeS Pharma Ventures (MViyeS). MViyeS is holding 32.18% shareholding in Eugia Pharma Specialities, a joint venture company in which the Company is holding 67.82%.

By this acquisition, both Eugia Pharma Specialities and MViyeS Pharma Ventures will become 100% subsidiaries of the Company.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1176.65 -40.80 (-3.35%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×